{"id":"https://openalex.org/W2082886342","doi":"https://doi.org/10.1160/th10-01-0025","title":"BMS-593214, an active site-directed factor VIIa inhibitor: Enzyme kinetics, antithrombotic and antihaemostatic studies","display_name":"BMS-593214, an active site-directed factor VIIa inhibitor: Enzyme kinetics, antithrombotic and antihaemostatic studies","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W2082886342","doi":"https://doi.org/10.1160/th10-01-0025","mag":"2082886342","pmid":"https://pubmed.ncbi.nlm.nih.gov/20589312"},"language":"en","primary_location":{"id":"doi:10.1160/th10-01-0025","doi":"https://doi.org/10.1160/th10-01-0025","is_oa":false,"landing_page_url":"https://doi.org/10.1160/th10-01-0025","pdf_url":null,"source":{"id":"https://openalex.org/S206235894","display_name":"Thrombosis and Haemostasis","issn_l":"0340-6245","issn":["0340-6245","2567-689X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and Haemostasis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046070580","display_name":"Joseph M. Luettgen","orcid":"https://orcid.org/0000-0002-5067-8819","observed_orcids":["https://orcid.org/0000-0002-5067-8819"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Luettgen","raw_affiliation_strings":["Thrombosis Research, Bristol-Myers Squibb Company, Pennington, New Jersey, USA","Thrombosis Research, Bristol-Myers Squibb Company, Pennington, New Jersey, USA. pancras.wong@bms.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thrombosis Research, Bristol-Myers Squibb Company, Pennington, New Jersey, USA","institution_ids":["https://openalex.org/I4210091812"]},{"raw_affiliation_string":"Thrombosis Research, Bristol-Myers Squibb Company, Pennington, New Jersey, USA. pancras.wong@bms.com","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002519621","display_name":"Alan R. Rendina","orcid":"https://orcid.org/0009-0003-9309-9651","observed_orcids":["https://orcid.org/0009-0003-9309-9651"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Rendina","raw_affiliation_strings":["Thrombosis Research, Bristol-Myers Squibb Company, Pennington, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thrombosis Research, Bristol-Myers Squibb Company, Pennington, New Jersey, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001682778","display_name":"Charles A. Kettner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Kettner","raw_affiliation_strings":["Discovery Chemistry, Bristol-Myers Squibb Company, Pennington, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Chemistry, Bristol-Myers Squibb Company, Pennington, New Jersey, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113520459","display_name":"Baomin Xin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Baomin Xin","raw_affiliation_strings":["Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Pennington, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Pennington, New Jersey, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084860922","display_name":"Robert M. Knabb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Knabb","raw_affiliation_strings":["Thrombosis Research, Bristol-Myers Squibb Company, Pennington, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thrombosis Research, Bristol-Myers Squibb Company, Pennington, New Jersey, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003421053","display_name":"Ruth R. Wexler","orcid":"https://orcid.org/0000-0001-5514-5053","observed_orcids":["https://orcid.org/0000-0001-5514-5053"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruth Wexler","raw_affiliation_strings":["Discovery Chemistry, Bristol-Myers Squibb Company, Pennington, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Chemistry, Bristol-Myers Squibb Company, Pennington, New Jersey, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040034830","display_name":"E. Scott Priestley","orcid":"https://orcid.org/0000-0001-8390-1143","observed_orcids":["https://orcid.org/0000-0001-8390-1143"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Scott Priestley","raw_affiliation_strings":["Discovery Chemistry, Bristol-Myers Squibb Company, Pennington, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Chemistry, Bristol-Myers Squibb Company, Pennington, New Jersey, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026904604","display_name":"Pancras C. Wong","orcid":"https://orcid.org/0000-0002-8224-7423","observed_orcids":["https://orcid.org/0000-0002-8224-7423"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Pancras Wong","raw_affiliation_strings":["Thrombosis Research, Bristol-Myers Squibb Company, Pennington, New Jersey, USA. pancras.wong@bms.com","Thrombosis Research, Bristol-Myers Squibb Company, Pennington, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thrombosis Research, Bristol-Myers Squibb Company, Pennington, New Jersey, USA. pancras.wong@bms.com","institution_ids":["https://openalex.org/I4210091812"]},{"raw_affiliation_string":"Thrombosis Research, Bristol-Myers Squibb Company, Pennington, New Jersey, USA","institution_ids":["https://openalex.org/I4210091812"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5026904604"],"corresponding_institution_ids":["https://openalex.org/I4210091812"],"apc_list":null,"apc_paid":null,"fwci":2.3537,"has_fulltext":false,"cited_by_count":31,"citation_normalized_percentile":{"value":0.89279186,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"104","issue":"08","first_page":"261","last_page":"269"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":0.007899999618530273,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/factor-viia-inhibitors","display_name":"factor VIIa inhibitors","score":0.8619999885559082},{"id":"https://openalex.org/keywords/tissue-factor","display_name":"tissue factor","score":0.7770000100135803},{"id":"https://openalex.org/keywords/competitive-inhibition","display_name":"competitive inhibition","score":0.6740000247955322},{"id":"https://openalex.org/keywords/non-competitive-inhibition","display_name":"non-competitive inhibition","score":0.7160000205039978},{"id":"https://openalex.org/keywords/arterial-thrombosis","display_name":"arterial thrombosis","score":0.8119999766349792},{"id":"https://openalex.org/keywords/venous-thrombosis","display_name":"venous thrombosis","score":0.9850000143051147},{"id":"https://openalex.org/keywords/bleeding-time","display_name":"bleeding time","score":0.847000002861023},{"id":"https://openalex.org/keywords/antithrombotic-efficacy","display_name":"antithrombotic efficacy","score":0.8370000123977661},{"id":"https://openalex.org/keywords/therapeutic-window","display_name":"therapeutic window","score":0.6069999933242798}],"concepts":[{"id":"https://openalex.org/C2777015399","wikidata":"https://www.wikidata.org/wiki/Q4775337","display_name":"Antithrombotic","level":2,"score":0.8778958320617676},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6624869108200073},{"id":"https://openalex.org/C186738567","wikidata":"https://www.wikidata.org/wiki/Q412841","display_name":"Tissue factor","level":3,"score":0.5905149579048157},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5734558701515198},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.47140172123908997},{"id":"https://openalex.org/C57002609","wikidata":"https://www.wikidata.org/wiki/Q5281999","display_name":"Discovery and development of direct thrombin inhibitors","level":4,"score":0.42311835289001465},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.421016126871109},{"id":"https://openalex.org/C2777292125","wikidata":"https://www.wikidata.org/wiki/Q409166","display_name":"Thrombin","level":3,"score":0.3937121033668518},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3884829878807068},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.19963020086288452},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1725544035434723},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1713205873966217}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001565","descriptor_name":"Benzoates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001760","descriptor_name":"Bleeding Time","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001777","descriptor_name":"Blood Coagulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002341","descriptor_name":"Carotid Artery Thrombosis","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002341","descriptor_name":"Carotid Artery Thrombosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002341","descriptor_name":"Carotid Artery Thrombosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006487","descriptor_name":"Hemostasis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006490","descriptor_name":"Hemostatics","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006490","descriptor_name":"Hemostatics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006576","descriptor_name":"Heterocyclic Compounds, 4 or More Rings","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D013925","descriptor_name":"Thromboplastin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015942","descriptor_name":"Factor VIIa","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D015942","descriptor_name":"Factor VIIa","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015951","descriptor_name":"Factor Xa","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020134","descriptor_name":"Catalytic Domain","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020246","descriptor_name":"Venous Thrombosis","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D020246","descriptor_name":"Venous Thrombosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020246","descriptor_name":"Venous Thrombosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1160/th10-01-0025","doi":"https://doi.org/10.1160/th10-01-0025","is_oa":false,"landing_page_url":"https://doi.org/10.1160/th10-01-0025","pdf_url":null,"source":{"id":"https://openalex.org/S206235894","display_name":"Thrombosis and Haemostasis","issn_l":"0340-6245","issn":["0340-6245","2567-689X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and Haemostasis","raw_type":"journal-article"},{"id":"pmid:20589312","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20589312","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and haemostasis","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320309383","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1967527579","https://openalex.org/W2104735281","https://openalex.org/W2131532163","https://openalex.org/W2134341825","https://openalex.org/W2333734569","https://openalex.org/W1977414977","https://openalex.org/W2980158212","https://openalex.org/W2314344222","https://openalex.org/W1819699650","https://openalex.org/W2080161513"],"abstract_inverted_index":{"Factor":[0],"(F)":[1],"VIIa":[2],"in":[3,12,31,55,59,106,149,155,163],"association":[4],"with":[5,113,135,152,173,188,199],"tissue":[6],"factor":[7],"(TF)":[8],"is":[9],"the":[10,32,38,90,107,126,129,164,209,215],"primary":[11],"vivo":[13],"initiator":[14],"of":[15,34,45,63,82,94,103,109,115,125,128,137,169,176,197,211,219],"blood":[16],"coagulation":[17],"and":[18,21,42,58,75,92,96,145,157,166,171,217,221],"activates":[19],"FX":[20,132],"FIX":[22],"to":[23,178,190],"generate":[24],"thrombin,":[25],"which":[26],"plays":[27],"a":[28,110,122,184,204],"key":[29],"role":[30],"pathogenesis":[33],"thrombosis.":[35],"We":[36],"evaluated":[37,87],"enzyme":[39],"kinetics,":[40],"antithrombotic":[41,206],"antihaemostatic":[43],"properties":[44],"BMS-593214,":[46],"an":[47],"active-site,":[48],"direct":[49],"FVIIa":[50,105,144,198],"inhibitor.":[51],"Studies":[52],"were":[53],"conducted":[54],"enzymatic":[56],"assays,":[57],"anesthetised":[60],"rabbit":[61,158],"models":[62,168],"electrically-induced":[64],"carotid":[65],"arterial":[66],"thrombosis":[67,73],"(AT),":[68],"thread-induced":[69],"vena":[70],"cava":[71],"venous":[72],"(VT)":[74],"cuticle":[76],"bleeding":[77],"time":[78],"(BT).":[79],"Antithrombotic":[80],"efficacy":[81],"BMS-593214":[83,98,140,160,182],"given":[84],"intravenously":[85],"was":[86,161],"for":[88,143,208,214],"both":[89],"prevention":[91,165,216],"treatment":[93,167,218],"AT":[95,170,220],"VT.":[97,222],"displayed":[99],"direct,":[100],"competitive":[101],"inhibition":[102,196],"human":[104,156],"hydrolysis":[108],"tripeptide":[111],"substrate":[112,131],"Ki":[114,136],"5":[116],"nM.":[117,139],"However,":[118],"it":[119],"acted":[120],"as":[121],"noncompetitive":[123],"inhibitor":[124],"activation":[127],"physiological":[130],"by":[133],"TF/VIIa":[134],"9.3":[138],"showed":[141],"selectivity":[142],"exhibited":[146,183],"species":[147],"differences":[148],"TF-FVIIa-dependent":[150],"anticoagulation":[151],"similar":[153],"potency":[154],"plasma.":[159],"efficacious":[162],"VT":[172],"ED50":[174],"values":[175],"1.1":[177],"3.1":[179],"mg/kg.":[180],"Furthermore,":[181],"wide":[185],"therapeutic":[186],"window":[187],"respect":[189],"BT.":[191],"These":[192],"results":[193],"suggest":[194],"that":[195],"small-molecule":[200],"active-site":[201],"inhibitors":[202],"represents":[203],"promising":[205],"approach":[207],"development":[210],"new":[212],"therapies":[213]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}